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Chapter 1- Introduction
Amyotrophic Lateral Sclerosis
Neurodegenerative diseases are among the most common diseases affecting aging
population including 50 million Americans targeted each year (Brown 2005). Neurodegenerative
diseases are characterized by death of neuronal cells. Neurons are post-mitotic, hence once the
cells die, there is no replenish of the lost neurons (Friedman 2011). There are many factors
contributing to the onset of neurodegenerative diseases. However, most common factors in
neurodegenerative diseases include 1) protein aggregation and 2) oxidative stress, which is
associated with mitochondria dysfunction (Sheikh 2012).
First discovered in 1869 by French neurologist Jean Martin Charcot, amyotrophic lateral
sclerosis (ALS) is a neurodegenerative disease affecting both upper and lower motor neurons
leading to paralysis and eventually death due to diaphragm failure (Redler 2012). Upper motor
neurons extend from the motor cortex in the brain and lower motor neurons extend from the
spinal cord to innervate skeletal muscles that allows for voluntary movement. Interestingly, ALS
does not affect cognitive ability, sensation, and autonomic function, such as breathing and
digestive process. It is currently the most common neurodegenerative disease affecting 1-2
person per 100,000 people worldwide (Redler 2012). Death usually occurs 2 to 5 years after
disease onset. In recent studies, the U.S ALS mortality rate is 1.84 per 100,000 persons.
There are two onset forms of ALS: either spinal or bulbar (Wijesekera 2009). Spinal ALS
onset is characterized by muscle weakness in upper and lower limbs. It also includes focal
muscle atrophy of upper and lower limbs along with fasciculations (spontaneous contraction) and
spasticity (pull). On the other hand, bulbar ALS onset is characterized by difficulty in speech,
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swallowing and develop excessive drooling. Bulbar onset also express fasciculations and
spasticity of the tongue. As ALS progresses, patients experience both spinal and bulbar traits
(Wijesekera 2009). Roughly 82% of ALS cases are sporadic showing no trace of hereditability
and about 5-10% cases are familial ALS (fALS) and autosomal dominant. Of the fALS cases,
20% are associated with mutations in superoxide dismutase 1 (SOD1). SOD1 is an enzyme that
scavenges toxic superoxide radicals to produce hydrogen peroxide (H2O2). To date, over 100
mutations in SOD1 have been identified as causative for fALS.
Protein aggregation
In neurodegenerative diseases, protein aggregates are found in the brain tissues and these
misfolded proteins can cause dysfunctions in neurons. It has been discovered that protein
aggregates in neurodegenerative diseases are usually in beta-sheet structures, which increase
protein rigidity (Takalo 2013). There are different proteins aggregates found in cases of ALS.
Aggregates of TAR binding DNA protein 43 (TDP-43), a gene regulator protein, are found in
neuronal and glial cells and localized to the cytoplasm from the nucleus of spinal cord motor
neurons in both sporadic and familial cases of ALS (Blokhuis 2013). Another mutated protein
associated with ALS is fused in sarcoma/translocated in liposarcoma (FUS), a nuclear protein.
FUS aggregates were initially discovered in fALS cases but then found in 1% of sALS cases.
These protein aggregates tend to cause dysfunction of the lower motor neurons (Blokhuis 2013).
Mutation in a protein with unknown function is characterized to be a major cause of fALS and is
called C9orf72 (chromosome 9 open reading frame 72) (Blitterswijk 2014). Normally, there are
hexanuceleotide GGGGCC repeats in this protein but it becomes toxic when there are hundreds
to a thousand repeats present, causing a gain-of-function in RNA (Blitterswijk 2014).
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Protein aggregates produce cell death because they can cause cellular important proteins
to misfold and aggregate to the growing protein aggregation causing those proteins to lose their
function and consequently cell survival might be affected. Cells have protective mechanisms
against protein aggregation called the protein quality control (PQC), which include chaperones
and ubiquitin-proteasome system (UPS) (Takalo 2013). Chaperone proteins help prevent protein
misfolding, disaggregate protein complexes, and cooperate with proteases to degrade proteins
with the aid of ATP hydrolysis (Lindberg 2015). Heat shock proteins are the largest chaperone
family and are upregulated under conditions of cellular stress including high temperature and
oxidative stress. The UPS targets proteins for degradation. Within the UPS, ligases (E1, E2, E3)
first recognize and tag misfolded proteins with a chain of four to five ubiquitin to lysine residues.
This tag is then recognized by 26R proteasome complex, a protease which degrades misfolded
proteins. The UPS is usually accompanied by chaperones to recruit the ligases and so both
chaperones and UPS work hand- in- hand to clear misfolded proteins. It has been hypothesized
that deficiencies in PQC system could also initiate protein accumulation and mutations in
proteins that play a role in aiding PQC (Takalo 2013).
Oxidative stress
Cellular oxidative stress is characterized by the formation of superoxide radicals, reactive
species which produce cellular toxicity through adduct formation, protein misfolding and lipid
peroxidation (Uttara 2009) which possess an extra unshared electron. Because the brain
consumes about 20-30% oxygen, making it the tissue utilizing the most oxygen in our body,
reactive oxygen species (ROS) are more prevalent and produce greater levels of toxicity than in
other tissues (Sultana 2013). Under normal conditions 1-2% of the oxygen is converted to ROSs
(Uttara 2009). In neurons the major producers of ROSs are NADPH oxidase and xanathine
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oxidase present in the cytosol and monoamine oxidase, complex I and complex III in the
mitochondria (Gandhi 2012). NADPH oxidase is an enzyme that donates an electron from
NADPH to oxygen to form superoxide (O2-); xanathine oxidase is an enzyme that transfers
electron to oxygen in order to form uric acid, superoxide, and hydrogen peroxide (Gandhi 2012).
Monoamine oxidase converts amine to aldehyde and hydrogen peroxide (Holschneider 2000).
Complex 1 and complex III are enzymes that play a role in oxidative phosphorylation on the
inner mitochondria membrane transferring electron from NADH to the final electron acceptor
oxygen (Gandhi 2012). Complex I releases superoxide to mitochondria matrix and complex III
releases superoxide to the inner mitochondria membrane (Hroudova 2014). Hence, dysfunction
of mitochondria can lead to oxidative stress and has been a characteristic in neurodegenerative
diseases (Gandhi 2012).
ROS are problematic because they are highly reactive due to their electron deficiency and
consequently participate in many redox reactions with macromolecules leading to a cascade of
redox reactions (Sultana 2013). ROS can cause carbonylation of proteins, which, in turn, produce
reactive ketones and aldehydes that react with other molecules and so on. Furthermore, ROS can
cause DNA breaks and DNA mutations by reacting with DNA backbone and individual nucleic
acid bases. ROS react with brain’s high concentration of polyunsaturated fatty acids (PUFA),
which are fatty acids containing more than one double bond in its structure, in neuronal
membranes (Sultana 2013). PUFA are important for signal transduction (Bazinet 2014) and ROS
breaks it down producing malondialdehyde which in turn disrupts proteins required for DNA
stability. (Gemma 2007). When there are too many ROSs for cells to overcome, cell toxicity
reaches its maximum and the cell dies (Fulda 2010).
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SOD1
Cu/Zn Superoxide dismutase 1 (SOD1) is an antioxidant enzyme that coverts superoxide
(O2-) to dioxide (O2) and (H2O2), which can then detoxify to water by oxidase (Banci 2008). It is
conserved throughout many organisms, including humans (Figure 1). SOD1 is a homodimer with
each SOD1 containing copper and zinc in its structure. Copper plays a catalytic role while zinc
plays a structural role (Rahkit 2006). The dimer also consists of a disulfide bond which holds the
two SOD1 units together (Sea 2015) and prevents it from aggregation if metal is deficient
(Franco 2013). It is noted that the metals promote the disulfide bonds (Redler 2012). When
SOD1 interacts with superoxide (O2-), it donates an electron from Cu2+ to oxide making
molecular oxygen (O2) and copper reduces to Cu+, which becomes Cu2+ again when it comes in
contact with another O2- and 2H to produce hydrogen peroxide (H2O2) (Franco 2013).
Mutations in SOD1 affect both protein aggregation along with oxidative stress. There are
roughly over 100 missense mutations in SOD1 that are associated with ALS. Interestingly, the
function of SOD1 is retained in the presence of a mutation. Moreover, transgenic mice with
SOD1 knockout did not develop ALS, leading to the idea that the function of SOD1 is not
required for onset of the disease (Redler 2012). Many experiments have discovered that there is a
correlation between increased mutant SOD1 aggregation and decreased survival time (Redler
2012). In human SOD1, there is a cysteine on the 111th amino acid sequence but a serine is
present in Drosophila SOD1 at the corresponding position. In previous study by Cozzolino et al.,
a mouse motorneuron cell line NSC-34 was transfected with human fALS associated mutant
SOD1. Mutants of human SOD1, C6F and G93A, formed insoluble aggregates in the cells.
However, in double mutants containing C111S, solubility of aggregates was increased and
toxicity decreased. Moreover, the presence of SOD1C111S increased solubility of triple mutant
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SOD1C6F/C57S/C146R and inhibited aggregate formation in SOD1G93A/C111S and SOD1C6F/C111S.
Furthermore, it was shown the wildtype SOD1 became insoluble in the presence of mutant
SOD1G93A but with co-transfection of SOD1G93A/C111S, insoluble SOD1wt recovered to it normal,
soluble state. These results led to the hypothesis that the 111Cysteine residue is essential to
aggregate formation and toxicity. To test this idea further, we modified the endogenous
Drosophila SOD1 gene to create SOD1S111C and assessed general toxicity through lethality
studies.
Drosophila melanogaster as a model of ALS
Drosophila melanogaster proves to be an excellent model organism to study disease
mechanisms in vivo for many reasons including a quick life cycle (10-14 days), a large number
of progeny, a small and fully sequenced genome with high conservation with mammals cheap
and easy maintenance, and most importantly, it contains many genes that have been conserved
among of mammalian (McGurk 2015). D. melanogaster has homolog of about 75% of human
genes making D. melanogaster a very valuable model organism to study genetic diseases
(Jackson 2008). Furthermore, D. melanogaster and human neurons share common cellular
components, like cell signaling and trafficking, which makes D. melanogaster even more
valuable to study neurodegenerative diseases (Sheikh 2013).
One key feature that makes D. melanogaster an important model organism is its ability to
undergo homologous recombination (Rong 2002). Homologous recombination is the process by
which D. melanogaster can exchange a part of its genomic DNA with an injected donor plasmid
DNA. This process leads to the manipulation of D. melanogaster genomic DNA and allows
researchers to study mutations and even study human genes (Rong 2002).
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In this thesis, we are testing the idea that human-like SOD1 will promote protein
aggregation since D. melanogaster-like SOD1 abolished protein aggregation. Additionally, we
are testing the eclosion ratio of D. melanogaster with SOD1S111C in the presence of another
mutation SOD1G85R to test the effect, if any, of SOD1S111C.
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Chapter 2- Materials and Methods
Materials
Drosophila Stocks with Bloomington Stock Numbers
5905 w1118
6934 y[1] w[*]; P{ry[+t7.2]=70FLP}11 P{v[+t1.8]=70I-SceI}2B sna[Sco]/CyO, S[2]
2475 w[*]; T(2;3)ap[Xa], ap[Xa]/CyO; TM3, Sb[1]
851 y[1] w[67c23] P{y[+mDint2]=Crey}1b; D[*]/TM3, Sb[1]
33821 w[1118]; wg[Sp-1]/CyO; sens[Ly-1]/TM6B, Tb[1]
5580 y[d2] w[1118] P{ry[+t7.2]=ey-FLP.N}2
Mutagenesis Primers
sod S111C 1 CGTCCGATGATGCAGTCGGCACCGAAG
sod S111C 2 CTTCGGTGCCGACTGCATCATCGGACG
Sequencing Primers
A2-S-F1

TTCCAAGGAATGCAACAGC

A2-S-F2

CTAGCGAAACGGAAGGAG

A2-S-F3

TTCGTCGAGCAACAAGTG

A2-S-F4

TACGGATTGAAGTGCGGTC

A2-S-R1

GATCTGGGCAACATTGAGG

A2-S-R2

ATCAAGATACTCGCCACATG

A2-S-R3

TCAGGCTGCTAAACGAAG

A2-S-R4

GACCAGAATAAAGGGCAGC
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Methods
Fly Care
D. melanogaster were obtained from Bloomington Drosophila Stock Center and kept at 23oC fly
incubator with a 12h/12h light/dark cycle and raised on standard Gelbart food.

Mutagenesis
Mutagenesis was performed on pW25.2sodwt vector that contained sodwt and ampR gene
(Figure 2) using QuikChange II Xl Site-Directed Mutagenesis Kit and then digested with EcoR1
enzyme. Five products of mutagenesis (1, 3, 6, 12, 13) were digested with Acc65i and Not1 to
isolate mutated arm-2. Arm-2 from clone 6 was cut-out from low melting agarose gel and ligated
with pW25.2SOD1wt without arm-2 using standard protocols. After isolating DNA by Qiagen
Mini Prep Kit purification, samples were sent to University of Rhode Island for Sanger
sequencing.

Injection and Homologous Recombination
pW25.2 vector containing SOD1S111C was sent to Genetics Service Inc. for injection into
the D. melanogaster embryos’ germ line cells.
Homologous recombination was performed based on protocols adopted from Staber et al
(2011). After receiving injected flies, the first step was to mate the injected flies with w1118 flies
and then cross the progeny with red eyes to Drosophila stock line 2475. we crossed the flies with
flpI-sceI/CYO and heat shocked the embryos for one hour to activate the enzyme flippase that
will excise the p-element out of the genomic DNA and the flies will then undergo homologous
recombination with the endogenous sod+ on the third chromosome. The final step was to excise
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the mini white gene and this was done by crossing the flies with fly stock containing Cre
recombinase.

Genomic DNA of D. melanogaster
I isolated heterozygous D. melanogaster [sodS111C/ sod+] DNA before crossing the flies
with Cre recombinase stock. I used GeneJet Genomic DNA Purification Kit; however, I eluted in
100 µl elution buffer instead of 200 µl to obtain a greater yield of DNA. After isolating genomic
DNA, I amplified the sod1 gene from the genomic DNA via PCR using PfuII polymerase
(Agilent). Cycling parameters consisted of 55 C annealing (30s), 72 C extension (2 min), 92 C
denaturing for 40 cycles.
Following Cre recombination to remove the mini-white gene, genomic DNA was isolated and
PCR was performed as described above. Then the samples were sent to University of Rhode
Island for sequencing with primer A2-S-R1.

Eclosion Rate
I crossed virgin females that contain pW25.2sodS111C/CYO on the second chromosome with
males that contained sodG85R/Tm3-Ser on the third chromosome. The cross resulted in four
different genotype progenies: [pW25.2sodS111C/+; sodG85R/+], [pW25.2sodS111C/+; TM3-Ser/+],
[CYO/+; sodG85R/+], [CYO/+; TM3-Ser/+]. I scored the number of progeny of each genotype
(Table 1).
I also scored progeny from three additional crosses to test the eclosion rate in the
presence of sodS111C. All the sod mutants were located on the third chromosome and had
undergone homologous recombination.
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[sodS111C/sodS111C] X [sodH71Y/TM3-Ser-GFP]
[sodS111C/sodS111C] X [sodloxp/sodloxp]
[sodS111C/sodS111C] X [sodG85R/TM3-Ser-GFP]
I scored the progeny on CO2 pad and performed a chi-square test (Table 2).
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Chapter 3- Results
Sod gene is highly conserved among eukaryotic organisms (Figure 1). If we focus just on
the 111th amino acid position, we can see that position to be highly conserved in most organisms
as well. However, in human sod there exists a cysteine in 111th position but a serine in
Drosophila sod. Previous work by Cozzolino et al. showed that human sodC111S abolished protein
aggregation in a mouse motor neuron cell line when this mutant protein was expressed in
combination with ALS-causing sod mutations (such as sodA4V). To test whether a cysteine is
associated with toxicity, our experimental approach was to mutate Drosophila sodwt to sodS111C
and assess phenotypes..
Mutagenesis
In order to model sodS111C in Drosophila we first had to create the mutation in a vector
that will be injected in Drosophila embryonic cells. We used pW25.2sodwt vector (Figure 2) to
introduce sodS111C via site-directed mutagenesis at the appropriate location. Our mutation of
interest is located in arm-2 within the sod gene. The ampR gene, coding for ampicillin resistance,
allowed us to select transformed bacterial cells containing the plasmid. The pW25.2 vector
serves as a construct for homologous recombination in Drosophila. Embedded between arm-1
and arm-2 is the presence of the mini-white marker gene and loxp that allowed us to trace our
mutation in Drosophila by the expression of red-eyes. The FRT sites are where flippase will
excise the P-element out of the genomic DNA to initiate homologous recombination.
We performed site-directed mutagenesis to introduce S111C into the Drosophila sod
gene. The process of mutagenesis can cause the vector to rearrange and to check for any
rearrangements in our vector, we digested our mutagenesis product with EcoR1 restriction
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enzyme. Following mutagenesis, the sod1 gene was cloned into the Drosophila transformation
vector and diagnostic digests were performed to verify the integrity of the clone. There are five
total EcoR1 sites within the plasmid clone with predicted sizes of 295 bp, 662 bp, 696 bp, 5350
Kb, 6570 Kb. After transformation, 18 ampicillin resistant colonies were selected at random,
and DNA was isolated from grown colonies. EcoRI restriction digests were performed to
determine the integrity of the clones. Among clones tested, 5 different banding patterns were
observed (Figure 3). None of the clones tested showed expected DNA fragments and we
inferred pW25.2SOD1S111C to have rearranged during mutagenesis.
To determine if the relevant portion of genomic sequence for sod1 was intact, we
performed Not1 and Acc65i digests because these restriction sites are located on both ends of
sod arm-2. After Not1 and Acc65i digest of samples we expected arm-2 to drop out producing 2
bands on a gel: 10 Kb band and 2.5 Kb band (Figure 4). Sample 6 was the only sample among
the five that gave us the expected 2 bands. Sample 6 was sequenced to confirm that we had the
S111C mutation in sod1 gene (Figure 5). We confirmed the presence our mutation because there
exists thymine peak in the proper location. Since the remaining vector of sample 6 was
rearranged, we ligated arm-2 of sample 6 to the properly arranged pW25.2SODwt vector without
arm-2. Now that we had a vector that contained S111C mutation, we wanted to amplify the
amount of the properly mutated vector by transforming it into competent E. coli cells, isolate and
sequence the DNA, and finally inject it into Drosophila embryonic cells.
Genomic DNA
In order to introduce sodS111C in Drosophila, the injected sod1S111C had to replace a copy
of the endogenous dsod1wt on the third chromosome and this was accomplished through
homologous recombination (Figure 6). Briefly, the sodS111C construct was injected into the
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Drosophila embryonic cells and introduced stably into the Drosophila genome by P-element
transposition. Stable insertion of the construct was determined by a dominant selectable red eye
marker. To determine heritability of the construct, we crossed the injected flies with w1118 stock
and scored for progeny with red-eyes. Once verified, the stable insertions were balanced to
prevent recombination and loss of the transposable element. Flies containing the stable insertion
were crossed to Drosophila stock line (2475) which contain balancer chromosomes (CyO for the
2nd chromosome and TM3Sb for the 3rd chromosome). To determine the location of the Pelement, flies that now expressed CyO and TM3Sb were crossed with Drosophila stock line
(2475) for a second time. Progenies that expressed red-eyes also expressed TM3Sb, but not CyO
showed that the location of our P-element was on the second chromosome. To excise the Pelement from the second chromosome so it can undergo homologous recombination with dsodwt
on the third chromosome, the flies were crossed with flpI-sceI/CYO and the eggs were heat
shocked for one hour. Heat shock activates the flippase enzyme and excise the P-element out of
the second chromosome at FRT sites and then undergo homologous recombination with the
wildtype sod gene, thus replacing endogenous sodwt with sodS111C. The product of homologous
recombination was determined by an eye color change and we screened 5 lines and identified 5
independent lines. In order to remove any disruptions in the sodS111C gene that might affect
expression, we removed the mini-white gene from the sodS111C intron. This was accomplished by
crossing the flies with Drosophila stock (line 851), expressing the Cre recombinase enzyme.
leaving behind sodS111C with only loxp embedded in the gene. Hence, the final product is
Drosophila in which sodS111C was knocked into the genome within the endogenous sod gene on
the third chromosome.
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Mid-way through the process of homologous recombination, we wanted to confirm that
the flies still contained our P-element in their genome. We isolated genomic DNA and amplified
only a portion of the sod gene that contained our S111C mutation (500 bp). The electrophoresis
of the amplified genomic heterozygous showed one clean band at 500 bp, as expected (Figure 7).
Sequencing of the heterozygous genomic DNA confirmed that the flies did have the mutated
sodS111C in their genome. The sequencing results (Figure 8) showed a large thymine band and a
small adenine band right underneath it. Since the genomic DNA was derived from heterozygous
flies, it contained one copy of the wild-type endogenous sod and one copy of the mutated
sodS111C, hence the reason why a thymine and an adenine bands are both present. Additionally, to
determine the presence of sodS111C in homozygous flies we isolated genomic DNA, amplified the
portion of the gene that contained our mutation and sequencing results showed us one clean
adenine peak at the expected location (Figure 9).
Analyzing Progeny Eclosion Rate in the Presence of sodS111C
To determine if the presence of sodS111C on the second chromosome will have any effects
in flies heterozygous for sodG85R, a mutation which causes ALS in humans and produces adult
lethal phenotypes in flies, we crossed virgin females [pW25.2sodS111C/CYO; +/+] with [+/+;
sodG85R/Tm3-Ser] males and that resulted in four different progeny genotypes, including a
double mutant [pW25,2sodS111C/+; sodG85R/+] (Figure 10). After scoring progeny eclosion rate,
we found that the eclosion percent of expected for all four progeny classes were 100% (Table 1).
Hence, all progeny types eclosed in Mendelian ratios. To take one step further, we also analyzed
the effects of sodS111C in the presence of other ALS-associated sod mutants on the third
chromosome to test if sodS111C will rescue flies containing other sod mutations. We crossed
homozygous sodS111C flies with heterozygous sodH71Y and also crossed homozygous sodS111C
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with heterozygous sodG85R. Additionally, we also crossed homozygous sodS111C with
homozygous sodloxp as a control. The eclosion percent of expected for sodS111C/sodH71Y and
sodS111C/loxp were 100%, whereas the eclosion percent of expected of sodS111C/sodG85R was
150%, with a p-value < .001 (Table 2).
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Chapter 5-Conclusions
This works describes the creation and partial phenotypic analysis of a point mutation
within the endogenous Drosophila sod gene. The sodS111C allele was generated through a process
of mutagenesis and homologous recombination in vivo. SodS111C stocks were created to analyze
the mutation’s influence on protein aggregation, if any. We were able to test the effects of this
mutant by assessing the function of the protein using genetic assays. To examine the effect of
sodS111C on the second chromosome in the presence of sodG85R on the third chromosome
appropriate genetic crosses were performed and it was determined that there was no significant
difference among the eclosion rates of progenies. All four genotypes of progenies eclosed in
Mendelian ratios. This could be explained by the fact that though one class of progeny genotype
contained a double mutant sod, there was still the presence of the endogenous sodwt that could
have masked for the double mutant.
We also assessed the eclosion rate of flies containing sodS111C in the presence of ALSassociated sod mutations to determine if S111C mutation rescue those sod mutations. There was
no effect in eclosion rate with the presence of sodS111C with sodH71Y and sodS111C with sodloxp.
However, there was a significant increase in the eclosion rate of sodS111C/sodG85R. This showed
that sodS111C rescued sodG85R because the presence of sodS111C and sodG85R lead to more fly
eclosions. Hence, it is safe to say that there was no effect on protein aggregation with one copy
of sodG85R and we can further conclude that sodS111C/sodG85R acts in a similar manner as
sodwt/sodG85R in Drosophila. In the presence of sodS111C, flies containing sodG85R seem to eclosed
in higher numbers than progenies that did not contain the sodG85R mutation. If sodS111C did not
function in a similar manner to the wildtype sod gene, then the eclosion rate of sodS111C/sodG85R
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would be lower than sodS111C/TM3Ser. The fact that our results were the opposite, showed that
the presence of sodS111C could have masked sodG85R, like the endogenous dsodwt in [sodS111C/+;
sodG85R/dsodwt]. Thus, we can conclude that sodS111C behaves in a similar manner as the
endogenous dsodwt.
In future studies, longevity experiments will be performed to assess the ability of S111C
to rescue pathogenic mutations over time as flies age.
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Figures

Figure 1. Clustal W alignment for SOD1 in selected model organisms. SOD1 protein shows a
high degree of evolutionary conservation. Highlighted areas represent areas of conservations and
arrow represents the site of S111C mutation.

19	
  
	
  

Figure 2. Cartoon depiction of pW25.2SOD1wt vector with ampicillin resistance gene. The
vector was obtained from Reenan lab at Brown University (Staber et al 2011). Arm-1 and arm-2
make up SOD1wt gene which is disrupted by mini white marker gene and loxp that allows us to
follow our vector in D. melanogaster. The FRT sites are where flippase is going to cut and
excise the vector out of D. melanogaster genome.
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Figure 3. EcoR1 digest of mutagenesis products of pW25.2SOD1wt. After mutagenesis, 2	
  µl
of products were digested with EcoR1 at 37oC for 2 hours and then ran on 1% agarose gel with 2
log ladder. Expected 3 band patterns but the gel showed five distinct patterns (a-e).
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Figure 4. Not1 and Acc65i digest of mutagenesis samples 1, 3, 6,12,13 (see Figure 3). Not1
and Acc65i isolate arm-2 from pW25.2 vector. Sample were digested for 2 hours at 37oC and
then ran on 1% agarose gel with 2 log ladder. Expected bands are arm-2 (2.5 Kb) and the
remaining vector (10 Kb). Lane 6 is the only sample that showed the expected bands.
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Figure 5. Sanger sequencing results of pW25.2SOD1S111C after the process of site-directed
mutagenesis. Vector was sent to University of Rhode Island. In wild-type SOD1wt (top), there
exist a thymine but after mutagenesis that thymine is mutated to an adenine (bottom).
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Figure 6. Process of homologous recombination in D. melanogaster with injected
pW25.2SOD1S111C. After injection, only the p-element incorporates into the genomic DNA.
Flippase excises the vector at FRT sites and then undergoes homologous recombination with D.
melanogaster’s third chromosome that contains the endogenous SOD1wt. Cre recombinase
removes the mini white gene between arm-1 and arm-2. In the end we have one copy on the
endogenous SOD1wt and one copy of SOD1S111C on the third chromosome.
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Figure 7. PCR amplification of sod from genomic DNA. Genomic DNA of heterozygous sod+
/sodS111C flies were isolated and amplified with primer set [F3A, R1A] on 1% agarose gel with 2
log ladder. The expected band is 500 bp.
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Figure 8. Sanger sequencing result of genomic D. melanogaster DNA. Heterozygous
sod+/sodS111C flies’ genomic DNA was isolated after homologous recombination and amplified
with primer A2-S-R1. Sample was sent to University of Rhode Island for sequencing. Arrow
shows thymine (T) from endogenous sod+ and adenine(A) from mutated sodS111C.
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Figure 9. Sanger sequencing result of genomic D. melanogaster DNA. Homozygous
sodS111C/sodS111C flies’ genomic DNA was isolated after homologous recombination and
amplified with primer A2-S-R1. Sample was sent to University of Rhode Island for sequencing.
(A) Top alignment shows the sequence of wildtype sod and the bottom alignment shows S111C
mutated sod sequence, with the red A denoting the mutation from thymine to adenine.
(B) Genomic DNA sequence of sodS11C peaks. Arrow shows the clean adenine peak, instead of
thymine, at the site of mutation.
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Figure 10. Crossing scheme of eclosion rate experiment. The diagram depicts only second and
third chromosome of D. melanogaster, where the pW25.2sodS111C vector and sodG85R are located
along with marker genes. The cross results in four different progeny types.
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Genotype
Eclosion % of Expected
Sample size (n)
pW25.2sodS111C/+; 100%
182
G85R
sod
/+
pW25.2sodS111C/+; 100%
160
TM3-Ser/+
CYO/+; sodG85R/+
100%
144
CYO/+; TM3-Ser/+ 100%
181
Table 1. Eclosion data of progeny from a cross involving heterozygotes of sodS111C and
sodG85R. Adult flies of genotypes pW25.2sodS111C/Cyo; +/+ and +/+; sodG85R/TM3-Ser were
crossed and eclosion numbers of the resulting F1 progeny were scored every other day.
Expected percentages were based on predicted Mendelian ratios.
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Genotype
Eclosion % of Expected
Sample Size (n)
S111C/H71Y
100%
688
S111C/loxp
100%
505
S111C/G85R
150% *
81
Table 2. Eclosion data of progeny from three crosses consisting of sodS111C. Progeny were
scored on CO2 pad every or every other day. Eclosion percent of expected was calculated as
(observed/sample size divided by expected) *P-value< .0001
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